Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia
- PMID: 17637480
- DOI: 10.1016/j.jhep.2007.05.012
Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia
Abstract
Background/aims: Because dietary modifications have prolonged the life expectancy of patients with glycogen storage disease type Ia (GSD Ia), the incidence of hepatocellular adenoma (HCA) to carcinoma (HCC) transformation is increasing. The objective of this retrospective study is to assess the safety and effectiveness of HCA resection in GSD Ia patients.
Methods: Clinicopathologic, peri-operative, and long-term data were reviewed from patients who underwent HCA resection. Comparisons were made with Fisher's exact, Mann-Whitney U, and log-rank tests; survival was estimated with Kaplan-Meier analysis.
Results: From 1998 to 2006, 38 patients underwent HCA resection. Seven (22%) had GSD Ia. Post-operative mortality occurred in one GSD Ia patient. GSD Ia patients had greater morbidity (86% vs. 20%) and shorter time to adenoma progression (median 23 months vs. not yet reached) after partial hepatectomy compared to the general population (p<0.05). Six GSD Ia patients had no evidence of HCC and recovered after resection without long-term morbidity. Three GSD Ia patients underwent liver transplantation 77, 32, and 23 months after adenoma resection.
Conclusions: Despite substantial morbidity, partial hepatectomy is feasible in GSD Ia patients and is an effective intermediate step in the prevention of HCC until definitive treatment with liver transplantation.
Similar articles
-
Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.Hum Mol Genet. 2009 Dec 15;18(24):4781-90. doi: 10.1093/hmg/ddp441. Epub 2009 Sep 16. Hum Mol Genet. 2009. PMID: 19762333
-
Liver transplantation for glycogen storage disease type Ia.J Hepatol. 2009 Sep;51(3):483-90. doi: 10.1016/j.jhep.2009.05.026. Epub 2009 Jun 17. J Hepatol. 2009. PMID: 19596478
-
Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation.Transpl Int. 2003 Dec;16(12):879-84. doi: 10.1007/s00147-003-0613-3. Epub 2003 Aug 7. Transpl Int. 2003. PMID: 12904843
-
[Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].Zentralbl Chir. 2009 Apr;134(2):127-35. doi: 10.1055/s-0028-1098881. Epub 2009 Apr 20. Zentralbl Chir. 2009. PMID: 19382043 Review. German.
-
Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population.Am J Surg. 2008 Jun;195(6):829-36. doi: 10.1016/j.amjsurg.2007.10.010. Epub 2008 Apr 23. Am J Surg. 2008. PMID: 18436176 Review.
Cited by
-
Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy.JIMD Rep. 2023 Aug 18;64(5):303-311. doi: 10.1002/jmd2.12381. eCollection 2023 Sep. JIMD Rep. 2023. PMID: 37701330 Free PMC article.
-
Gene therapy for glycogen storage diseases.J Inherit Metab Dis. 2024 Jan;47(1):93-118. doi: 10.1002/jimd.12654. Epub 2023 Jul 27. J Inherit Metab Dis. 2024. PMID: 37421310 Review.
-
Liver transplantation for benign liver tumors.World J Hepatol. 2021 Sep 27;13(9):1098-1106. doi: 10.4254/wjh.v13.i9.1098. World J Hepatol. 2021. PMID: 34630877 Free PMC article. Review.
-
"Bull's eye" appearance of hepatocellular adenomas in patients with glycogen storage disease type I - atypical magnetic resonance imaging findings: Two case reports.World J Clin Cases. 2021 Feb 6;9(4):871-877. doi: 10.12998/wjcc.v9.i4.871. World J Clin Cases. 2021. PMID: 33585634 Free PMC article.
-
Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.Insights Imaging. 2021 Jan 12;12(1):8. doi: 10.1186/s13244-020-00928-w. Insights Imaging. 2021. PMID: 33432491 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
